Abstract:Various heteroaryl and bicyclo-aliphatic analogues of zwitterionic biaryl P2Y14 receptor (P2Y14R) antagonists were synthesized, and affinity was measured in P2Y14R-expressing Chinese hamster ovary cells by flow cytometry. Given this series' low water solubility, various polyethylene glycol derivatives of the distally binding piperidin-4-yl moiety of moderate affinity were synthesized. Rotation of previously identified 1,2,3-triazole attached to the central m-benzoic acid core (25) provided moderate affinity but not indole and benzimidazole substitution of the aryl-triazole. The corresponding P2Y14R region is predicted by homology modeling as a deep, sterically limited hydrophobic pocket, with the outward pointing piperidine moiety being the most flexible. Bicyclic-substituted piperidine ring derivatives of naphthalene antagonist 1, e.g., quinuclidine 17 (MRS4608, IC50 ≈ 20 nM at hP2Y14R/mP2Y14R), or of triazole 2, preserved affinity. Potent antagonists 1, 7a, 17, and 23 (10 mg/kg) protected in an ovalbumin/Aspergillus mouse asthma model, and PEG conjugate 12 reduced chronic pain. Thus, we expanded P2Y14R antagonist structure–activity relationship, introducing diverse physical–chemical properties.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c00745?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00745</a>.Synthesis of additional compounds (4-bromophenyl intermediates and carboxylate substitutions on the central phenyl ring of 2); off-target binding inhibition curves; pharmacological data; molecular modeling data, including docking poses of selected compounds, number of contacts between the receptor residues and the ligand in each MD replicate, RMSD and ligand–receptor interaction pattern during MD replicate 3, RMSD and ligand-receptor interaction pattern during MD replicate 4, and analysis of MD replicates; predicted pharmacokinetic parameters; predicted log D and log S; and methods to measure solubility and lipohilicity (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00745/suppl_file/jm0c00745_si_001.pdf">PDF</a>)NMR and mass spectra of final compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00745/suppl_file/jm0c00745_si_006.pdf">PDF</a>)3D coordinates of hP2Y14R in complex with 17, obtained through molecular docking (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00745/suppl_file/jm0c00745_si_002.pdb">PDB</a>)MD trajectory (replicate 3) of the complex between compound 17 and hP2Y14R, after alignment of the receptor Cα atoms to the initial frame (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00745/suppl_file/jm0c00745_si_003.mp4">MP4</a>)MD trajectory (replicate 4) of the complex between compound 17 and hP2Y14R, after alignment of the receptor Cα atoms to the initial frame (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00745/suppl_file/jm0c00745_si_004.mp4">MP4</a>)Molecular formula strings of P2Y14R antagonists (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00745/suppl_file/jm0c00745_si_005.pdf">PDF</a>)This article has not yet been cited by other publications.

Structure-activity relationship studies on a series of novel, substituted 1-benzyl-5-phenyltetrazole P2X7 antagonists.

Design, Synthesis, And Sar Studies Of Heteroarylpyrimidines And Heteroaryltriazines As Cb2r Ligands

Synthesis and in Vitro Activity of N′-cyano-4-(2-phenylacetyl)-N-o-tolylpiperazine-1-carboximidamide P2X7 Antagonists

β-Lactam TRPM8 Antagonists Derived from Phe-Phenylalaninol Conjugates: Structure-Activity Relationships and Antiallodynic Activity

An investigation on linker modifications of cyanoguanidine‐based P2X7 receptor antagonists

Synthesis and Structure–Activity Relationship Studies of Benzimidazole-4,7-dione-Based P2X3 Receptor Antagonists as Novel Anti-Nociceptive Agents

Naphtho[1,2-b][1,4]diazepinedione-based P2X4 Receptor Antagonists from Structure-Activity Relationships Study Towards PET Tracer Development

From lead to clinic: A review of the structural design of P2X7R antagonists

Discovery of Triazolopyrimidine Derivatives as Selective P2X3 Receptor Antagonists Binding to an Unprecedented Allosteric Site as Evidenced by Cryo-Electron Microscopy

Isoquinolone derivatives as lysophosphatidic acid receptor 5 (LPA5) antagonists: Investigation of structure-activity relationships, ADME properties and analgesic effects

P2X7 receptors exhibit at least three modes of allosteric antagonism

Structure activity relationship studies of 6α- and 6β-indolylacetamidonaltrexamine derivatives as bitopic mu opioid receptor modulators and elaboration of the 'message-address concept' to comprehend their functional conversion.

Structure-Activity Relationships and Therapeutic Potential of Purinergic P2X7 Receptor Antagonists

Synthesis and SAR of Novel 4,5-Diarylimidazolines As Potent P2X7 Receptor Antagonists.

Discovery of Fused Heterocyclic Carboxamide Derivatives As Novel Α7-Nachr Agonists: Synthesis, Preliminary SAR and Biological Evaluation.

Identification of Novel P2X7R Antagonists by Using Structure‐based Virtual Screening and Cell‐based Assays

Α-Aryl Pyrrolidine Sulfonamides As TRPA1 Antagonists

Design, Synthesis and Anti-Inflammatory Evaluation of 3-Amide Benzoic Acid Derivatives As Novel P2Y14 Receptor Antagonists.

Exploration of Alternative Scaffolds for P2Y 14 Receptor Antagonists Containing a Biaryl Core

[3H]A-804598 ([3H]2-cyano-1-[(1S)-1-phenylethyl]-3-quinolin-5-ylguanidine) is a novel, potent, and selective antagonist radioligand for P2X7 receptors

Design, Synthesis and Biological Activities of Piperidine-Spirooxadiazole Derivatives As Α7 Nicotinic Receptor Antagonists